BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:IBD Symposium
X-WR-TIMEZONE:Eastern Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260811T165709Z
UID:tag:localist.com\,2008:EventInstance_52631338063846
DTSTART:20260724T110000Z
DTEND:20260724T203000Z
DESCRIPTION:Program Overview \n\nThe Fifth Annual Medical\, Interventional\
 , Surgical IBD Symposium will bring together leading experts in gastroente
 rology\, surgery\, and interventional medicine to explore the latest advan
 cements in the management and treatment of inflammatory bowel disease (IBD
 ). This one-day\, CME-accredited event will focus on medical therapies\, d
 iagnostic challenges\, IBD mimics\, complications\, and surgical intervent
 ions. The program will feature lectures from renowned specialists\, follow
 ed by a case discussion session to provide practical insights into complex
  clinical scenarios. The symposium is structured to provide in-depth knowl
 edge and updates on the current state of IBD therapies\, including biologi
 cs\, small molecular agents\, and endoscopic treatments. Experts will also
  present strategies for managing IBD complications\, such as cancer risks 
 and postoperative monitoring. The interactive case discussions will offer 
 participants an opportunity to engage with the panel of experts to review 
 real-world clinical cases.\n\nLearning Objectives:\n\nUnderstand and apply
  the latest advancements in medical therapies for IBD\, including anti-IL2
 3 therapy\, anti-TNF therapy\, and small-molecule agents\, to optimize pat
 ient outcomes.Evaluate and manage the diagnostic challenges of IBD\, inclu
 ding differentiating IBD from IBD mimics and identifying complications suc
 h as adenocarcinoma and squamous cell carcinoma in IBD patients.Assess and
  develop individualized surgical treatment plans for IBD patients\, includ
 ing postoperative monitoring\, endoscopic therapy\, and the appropriate us
 e of surgical interventions in Crohn’s disease and ulcerative colitis. \
 n\nTarget Audience\n\nThis program has been designed for regional\, nation
 al\, and worldwide audiences\, including gastroenterologists\, inflammator
 y bowel disease specialists\, GI endoscopists\, colorectal surgeons\, gene
 ral surgeons\, GI pathologists\, GI radiologists\, NP/PA/RN in gastroenter
 ology\, IBD\, and colorectal surgery\, stoma nurses\, medical students\, m
 edical/surgical residents\, and GI/colorectal fellows.\n\n \n\nJoint Accre
 ditation Statement\n\nIn support of improving patient care\, this activity
  has been planned and implemented by Columbia University Department of Sur
 gery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation
  Council for Continuing Medical Education (ACCME)\, the Accreditation Coun
 cil for Pharmacy Education (ACPE)\, and the American Nurses Credentialing 
 Center (ANCC)\, to provide continuing education for the healthcare team.
GEO:40.841164;-73.942924
LOCATION:Vivian and Seymour Milstein Family Heart Center
SUMMARY:IBD Symposium
URL;VALUE=URI:https://events.nyp.org/event/ibd-symposium-3696
CATEGORIES:For Professionals
CATEGORIES:Continuing Medical Education
END:VEVENT
END:VCALENDAR
